David B. Haslam, MD
- Director, Antimicrobial Stewardship Program
- Director, Microbial Genomics and Metagenomics Laboratory
- Professor, UC Department of Pediatrics
- david.haslam@cchmc.org
- Board Certified
About
Biography
I was influenced by my father, who was a pediatrician and took great satisfaction in caring for children. As a pediatric infectious disease specialist, I work with my patients and their families as a team and feel that taking care of children is a wonderful privilege and a responsibility.
In my practice, I try to be flexible by coordinating my patients' appointments with those of other providers when possible. I'm committed to providing continuity and to being accessible between visits.
I'm the director of the Antimicrobial Stewardship Program and the Microbial Genomics and Metagenomics Laboratory. I've received several teaching and research awards, including the Pediatric Infectious Disease Society Young Investigator Award.
The main focus of my research is on the microbiome, which is the community of bacteria, viruses, fungi and other organisms that live on the human body. The goal is to understand how the microbiome influences disease and contributes to health in children. A healthy microbiome helps protect against infection, allergy, gastrointestinal diseases, heart disease, diabetes and diseases of premature infants.
In my free time, I enjoy riding my bike.
MD: University of Calgary, Calgary, Alberta.
Rotating Internship: McGill University, Montreal, Quebec.
Residency: University of Ottawa, Ottawa, Quebec.
Fellowship: Washington University School of Medicine, St. Louis, MO.
Services and Specialties
Research Areas
Insurance Information
Cincinnati Children's strives to accept a wide variety of health plans. Please contact your health insurance carrier to verify coverage for your specific benefit plan.
Publications
Complement-producing maternal microchimeric cells override infection susceptibility in complement-deficient murine offspring. The Journal of Clinical Investigation. 2025; 135:e187001.
Characterization of initial CLABSI culture results to support antimicrobial de-escalation in pediatric GI inpatients. Journal of Pediatric Gastroenterology and Nutrition. 2024; 78:1234-1240.
Farm animal exposure, respiratory illnesses, and nasal cell gene expression. Journal of Allergy and Clinical Immunology. 2024; 153:1647-1654.
A randomized phase 2 trial of oral vitamin A for graft-versus-host disease in children and young adults. Blood. 2024; 143:1181-1192.
Acute pancreatitis is associated with gut dysbiosis in children. Digestive and Liver Disease. 2024; 56:444-450.
The Scrubbing Olympics. Transplantation and Cellular Therapy. 2024; 30:s69-s70.
Administration of Human Milk Oligosaccharide (2′-fucosyllactose) Reduces Dysbiosis and Increases Short Chain Fatty Acids in Children and Young Adults Following HSCT: A Prospective, Single-Center Study. Transplantation and Cellular Therapy. 2024; 30:s16.
Non–Group A or B Streptococci. Nelson Textbook of Pediatrics: Volume 1-2. 2024.
Enterococcus. Nelson Textbook of Pediatrics: Volume 1-2. 2024.
Thermoneutral Housing Enables Studies of Vertical Transmission of Obesogenic Diet-Driven Metabolic Diseases. Nutrients. 2023; 15:4958.
From the Blog
Without a Healthy Immune System, Too Much ‘Good’ Bacteria Can Become a Bad Thing
David B. Haslam, MD, Theresa Alenghat, VMD, PhD ...2/15/2023
3333 Burnet Avenue, Cincinnati, Ohio 45229-3026
© 1999-2025 Cincinnati Children's Hospital Medical Center. All rights reserved.
Patient Ratings and Comments
All patient satisfaction ratings and comments are submitted by actual patients and verified by a leading independent experience management company, Qualtrics. Patient identities are withheld to ensure confidentiality and privacy. Only those providers whose satisfaction surveys are administered through Cincinnati Children’s Hospital Medical Center are displayed. Click here to learn more about our survey